Dr James Anthony Calabro, MD | |
4092 Foxwood Dr, Virginia Beach, VA 23462-5225 | |
(757) 467-4200 | |
Not Available |
Full Name | Dr James Anthony Calabro |
---|---|
Gender | Male |
Speciality | Emergency Medicine |
Location | 4092 Foxwood Dr, Virginia Beach, Virginia |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1235160516 | NPI | - | NPPES |
5875021 | Medicaid | VA |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207P00000X | Emergency Medicine | 0101232093 (Virginia) | Primary |
Entity Name | Emergency Physicians Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1285686675 PECOS PAC ID: 7911811435 Enrollment ID: O20040407000673 |
News Archive
GeneNews Limited, a company focused on developing simple blood-based biomarker tests for the early detection of diseases and personalized health management, today announced it has signed an agreement with an Asian Biomedical consortium to develop blood-based biomarkers for the detection and management of prostate diseases.
PolyMedix, Inc. an emerging biotechnology company focused on developing new therapeutic drugs to treat infectious diseases and acute cardiovascular disorders, has received regulatory clearance from the United States Food and Drug Administration (FDA) for its Investigational New Drug (IND) application for PMX-30063, a synthetic defensin-mimetic antibiotic.
UCB, a leading biopharmaceutical company at the forefront of immunology treatment and research, will present new data on Cimzia at the American College of Gastroenterology (ACG) Annual Scientific Meeting, taking place in Washington D.C. from October 28 to November 2.
Every year in Canada about 50,000 people suffer from a stroke, caused either by the interruption of blood flow or uncontrolled bleeding in the brain. While many environmental risk factors exist, including high blood pressure and smoking, stroke risk is also frequently inherited. Unfortunately, remarkably little is known regarding stroke's genetic basis.
› Verified 6 days ago
Entity Name | Paragon Emergency Services Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1912101650 PECOS PAC ID: 8628153087 Enrollment ID: O20080310000143 |
News Archive
GeneNews Limited, a company focused on developing simple blood-based biomarker tests for the early detection of diseases and personalized health management, today announced it has signed an agreement with an Asian Biomedical consortium to develop blood-based biomarkers for the detection and management of prostate diseases.
PolyMedix, Inc. an emerging biotechnology company focused on developing new therapeutic drugs to treat infectious diseases and acute cardiovascular disorders, has received regulatory clearance from the United States Food and Drug Administration (FDA) for its Investigational New Drug (IND) application for PMX-30063, a synthetic defensin-mimetic antibiotic.
UCB, a leading biopharmaceutical company at the forefront of immunology treatment and research, will present new data on Cimzia at the American College of Gastroenterology (ACG) Annual Scientific Meeting, taking place in Washington D.C. from October 28 to November 2.
Every year in Canada about 50,000 people suffer from a stroke, caused either by the interruption of blood flow or uncontrolled bleeding in the brain. While many environmental risk factors exist, including high blood pressure and smoking, stroke risk is also frequently inherited. Unfortunately, remarkably little is known regarding stroke's genetic basis.
› Verified 6 days ago
Entity Name | Lake Oliver Emergency Group, Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1013675016 PECOS PAC ID: 4688060940 Enrollment ID: O20220413002299 |
News Archive
GeneNews Limited, a company focused on developing simple blood-based biomarker tests for the early detection of diseases and personalized health management, today announced it has signed an agreement with an Asian Biomedical consortium to develop blood-based biomarkers for the detection and management of prostate diseases.
PolyMedix, Inc. an emerging biotechnology company focused on developing new therapeutic drugs to treat infectious diseases and acute cardiovascular disorders, has received regulatory clearance from the United States Food and Drug Administration (FDA) for its Investigational New Drug (IND) application for PMX-30063, a synthetic defensin-mimetic antibiotic.
UCB, a leading biopharmaceutical company at the forefront of immunology treatment and research, will present new data on Cimzia at the American College of Gastroenterology (ACG) Annual Scientific Meeting, taking place in Washington D.C. from October 28 to November 2.
Every year in Canada about 50,000 people suffer from a stroke, caused either by the interruption of blood flow or uncontrolled bleeding in the brain. While many environmental risk factors exist, including high blood pressure and smoking, stroke risk is also frequently inherited. Unfortunately, remarkably little is known regarding stroke's genetic basis.
› Verified 6 days ago
Mailing Address | Practice Location Address |
---|---|
Dr James Anthony Calabro, MD Po Box 7549, Portsmouth, VA 23707-0549 Ph: (757) 686-3508 | Dr James Anthony Calabro, MD 4092 Foxwood Dr, Virginia Beach, VA 23462-5225 Ph: (757) 467-4200 |
News Archive
GeneNews Limited, a company focused on developing simple blood-based biomarker tests for the early detection of diseases and personalized health management, today announced it has signed an agreement with an Asian Biomedical consortium to develop blood-based biomarkers for the detection and management of prostate diseases.
PolyMedix, Inc. an emerging biotechnology company focused on developing new therapeutic drugs to treat infectious diseases and acute cardiovascular disorders, has received regulatory clearance from the United States Food and Drug Administration (FDA) for its Investigational New Drug (IND) application for PMX-30063, a synthetic defensin-mimetic antibiotic.
UCB, a leading biopharmaceutical company at the forefront of immunology treatment and research, will present new data on Cimzia at the American College of Gastroenterology (ACG) Annual Scientific Meeting, taking place in Washington D.C. from October 28 to November 2.
Every year in Canada about 50,000 people suffer from a stroke, caused either by the interruption of blood flow or uncontrolled bleeding in the brain. While many environmental risk factors exist, including high blood pressure and smoking, stroke risk is also frequently inherited. Unfortunately, remarkably little is known regarding stroke's genetic basis.
› Verified 6 days ago
Ioliene Boenau, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 3914 W Stratford Rd, Virginia Beach, VA 23455 Phone: 757-460-5924 | |
Moss H Mendelson, MD Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 4092 Foxwood Dr, Suite 101, Virginia Beach, VA 23462 Phone: 757-467-4200 | |
Anthony C Cetrone, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 6632 Indian River Rd, Virginia Beach, VA 23464 Phone: 757-424-4300 Fax: 757-523-0632 | |
Dr. Natalie Sobota Feldman, M.D. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 4092 Foxwood Dr, Ste 101, Virginia Beach, VA 23462 Phone: 757-686-3508 Fax: 757-686-0541 | |
Christopher L Gibert, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 4092 Foxwood Dr, Suite 101, Virginia Beach, VA 23462 Phone: 757-467-4200 | |
Dr. Andy Cameron Bunch, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 4092 Foxwood Dr Ste 101, Virginia Beach, VA 23462 Phone: 757-467-4200 | |
Beverly Nyokabi, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 4445 Corporation Ln Ste 264, Virginia Beach, VA 23462 Phone: 540-776-4028 |